News & Events

dyconex_logo_25years
12.05.2016

DYCONEX celebrates its 25th anniversary

DYCONEX AG, an MST company and the world's leading provider of highly complex solutions in the area of interconnect technology, will celebrate its 25th anniversary in September 2016.

MST at Medical Manufacturing Asia 2016

medical_manufacturing_asia_108px

Manufacturing Processes for Medical Technology
August 31 - September 2, 2016
Marina Bay Sands, Singapore
Booth# 2M17

MST at Medical Electronics Symposium 2016

medical_electronics_conference_200_px

Microelectronics
September 14 - 15, 2016
Marylhurst University, Portland, OR, USA

DYCONEX at PCB West 2016

pcb_west_108px

PCB Industry
September 13 - 15, 2016
Convention Center, Santa Clara, CA, USA
Booth# 518 


DYCONEX LIQUID CRYSTAL POLYMER (LCP) SUBSTRATE PROVES CYTOTOXICITY CONFORMITY ACCORDING TO ISO 10993-5

Cytotoxicity, a standardized test for materials used in medical devices, is used to determine if significant quantities of harmful extractable substances are present and how these may negatively affect cellular components. Harlan Cytotest Cell Research GmbH recently performed a cytotoxicity test on an LCP product manufactured by DYCONEX and certified in an official declaration the non-cytotoxicity of the product and it's suitability for in-vitro application.

Due to its biocompatibility, hermeticity properties, chemical inertness and advantageous electromechanical properties, LCP circuit boards are especially well-suited for biomedical and temporary implantable applications.